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Expression studies with skeletal  and  cardiac  muscle 
cDNAs have suggested that the putative cytoplasmic 
loop  region of the dihydropyridine  receptor  (DHPR) a1 
subunit  between  transmembrane  repeats I1 and I11 
(DCL) is a major  determinant of the  type of excitation- 
contraction coupling (skeletal or cardiac) in rescued 
dysgenic  muscle cells (Tanabe, T., Beam, K. G., Adams,  B. 
A., Niidome, T.,  and  Numa, S. (1990) Nature 346,567-569). 
In this study, the possibility of a  direct  functional  inter- 
action with the sarcoplasmic  reticulum  ryanodine 
receptor/Ca2+ release channel has been tested by ex- 
pressing the DCLs of the mammalian  skeletal  and  car- 
diac  muscle DHPR cul subunit in Escherichia coli. The 
purified peptides activated the skeletal muscle  ryano- 
dine  receptor/Ca2+ release channel  in single channel  and 
[SH]ryanodine  binding  measurements, by increasing 
channel  open  probability  and the affinity of [SHlryano- 
dine  binding,  respectively. The  two peptides  did  not  ac- 
tivate the cardiac muscle Ca2+ release channel. Other 
proteins (polylysine, serum  albumin) also increased 
[SH]ryanodine  binding  and  Ca2+ release channel activ- 
ity,  but  their  activation  mechanisms  were  distinguish- 
able from  DCLs. These results show  that the 11-111 cyto- 
plasmic loop of the skeletal and cardiac DHPR a1 
subunit  functionally interacts with  the skeletal, but  not 
cardiac,  muscle  Ca2+ release channel.  Furthermore, our 
studies suggest that in addition to the DHPR, the  sarco- 
plasmic  reticulum  Ca2+ release channel may determine 
the type of E-C coupling  that exists in muscle. 
The  mechanisms of excitation-contraction  (E-C)l  coupling  in 
skeletal  and  cardiac  muscle  differ  in  their  dependence  on  ex- 
tracellular  Ca2+.  In  cardiac  muscle,  the  entry of extracellular 
Ca2+ via a voltage-sensitive  dihydropyridine  receptor  (DHPR)/ 
Ca2+  channel  is  required  to  trigger  Ca2+  release  from  the  sar- 
coplasmic  reticulum  (SR) (1-3). In  contrast,  in  skeletal  muscle 
an action  potential  triggers  the  release of Ca2+  from  SR  in  the 
absence of extracellular Ca2+ (4). As a consequence, skeletal 
muscle  E-C  coupling has been  suggested  to  occur  by a mechani- 
cal  coupling  mechanism  involving  protein-protein  interactions 
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between  the  voltage-sensing  DHPR  located  in  the  tubular  in- 
foldings  (T-tubule) of the  surface  membrane  and  the  ryanodine 
receptor  (RYR)/Ca2+  release  channel  located  in  the SR mem- 
brane (5). 
The skeletal and cardiac RYRs are  homologous channels 
comprised of four M ,  - 565,000 polypeptides (6). Similarly, the 
two  muscle  DHPRs are related  oligomeric  complexes  comprised 
of up  to five different  subunits (7). One of the major  subunits 
(al) binds  Ca2+  channel  antagonists,  conducts  Ca2+  ions,  and 
displays  significant  sequence homology with the Na+  channel. 
The  main  putative  cytoplasmic  regions f the DHPR a1 subunit 
include  the  amino-  and  carboxyl-terminal  regions  and the loop 
regions  between  transmembrane  repeats I and 11, and I1 and 
111. These  cytoplasmic  regions  exhibit  major  differences  in  pri- 
mary  sequence  between the skeletal (8) and  cardiac (9) muscle 
DHPRs  and  accordingly  represent  regions of the DHPR that 
could confer  tissue  specificity  to the functional  interaction be- 
tween  the  cardiac  and  skeletal  DHPRs  and RYRs. 
Valuable insights into the sequences involved in the func- 
tional  coupling of the  DHPR  and RYR have  been  obtained  in 
expression studies with a dysgenic mouse model. Dysgenic 
skeletal  muscle  cultures are incapable of E-C  coupling  because 
they  lack the a1 subunit of the DHPR (10). Injection of the 
skeletal a1 DHPR cDNA restored E-C coupling in  the  absence 
of extracellular  Ca2+,  suggesting  restoration of skeletal  muscle- 
type  E-C  coupling (11). In  contrast,  cardiac-type  E-C  coupling 
was  observed following the injection of cardiac a1 DHPR cDNA 
since its restoration  required  extracellular  Ca2+ (12). Studies 
with cardiac and skeletal muscle chimeric cDNAs suggested 
that the 11-111 loop region of the DHPR a1 subunit  is a major 
determinant  for  the  type of E-C  coupling  (skeletal  or  cardiac) 
observed  in  dysgenic  muscle  cells (131, implying that this loop 
may  functionally  interact  with  the RYR. The  interaction of the 
11-111 loop region  with  the  cardiac RYR and  the role of the RYR 
isoforms  in  determining  cardiac- or skeletal-type  E-C  coupling 
have  not  been  described. 
Here  we  report  that the putative  cytoplasmic loops between 
transmembrane  repeats I1 and I11 of the  skeletal  and  cardiac 
muscle a1 DHPR  expressed  in E. coli activate the skeletal  but 
not  the  cardiac  muscle  Ca2+  release  channel.  Our  studies  sug- 
gest  that,  in  addition  to  the  DHPR,  the  SR  Ca2+  release  channel 
may  determine  the  type of E-C  coupling that exists  in  muscle. 
EXPERIMENTAL PROCEDURES 
Materials-PHlRyanodine  (54.7 Cilmmol) was obtained from DuPont 
NEN. Unlabeled  ryanodine was from AgriSystems International (Wind 
Gap, PA). Plasmid pETlld, E. coli strain BL21(DE3) and T7.Tag mono- 
clonal antibody were from Novagen (Madison, WI). DEAE-Sephacel, 
hydroxyapatite, SDS-PAGE molecular weight markers, bovine serum 
albumin (BSA), insulin, cytochrome c,  polylysine ( M ,  26,3001, and poly- 
glutamate ( M ,  13,300) were purchased from Sigma, and phospholipids 
from Avanti (Birmingham, AL). All other chemicals were of analytical 
grade. 
Expression and Purification of SDCL and CDCL-cDNAs encoding 
SDCL (GhP6 to Leu791) (8 )  or CDCL (Asp788  to GlnSz2) (9) were ampli- 
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fied  by reverse  transcription PCR from rabbit  skeletal  and heart muscle 
mRNA, respectively. The nucleotide sequences of cloned  PCR products 
were determined and showed agreement with those published. The PCR 
products were cloned into the BamHI site of pETlld expression vector 
with in-frame insertion. The recombinant plasmids pETlld-sdcl or 
pETlld-cdcl were expressed in E. coli strain BL21(DE3) as  described 
elsewhere (14). Cells were washed twice with 20 mM Na-Hepes, pH 7.4, 
0.2 m~ phenylmethylsulfonyl fluoride, 10 p~ leupeptin, and  fragmented 
by sonication for 3 x 20 s using a 6-mm  probe. After removal of particu- 
late  material by centrifugation a t  60,000 rpm for 15 min in a Beckman 
TL100.3 rotor, the  supernatant fraction was loaded onto a 5-ml DEAE- 
Sephacel column equilibrated  with 20 mM Na-Hepes, pH 7.4, a t  4 "C. 
The column was washed with 50 ml of 20 mM Na-Hepes, pH 7.4, and 
proteins were eluted with a 0-200 m~ NaCl gradient. SDCL and CDCL 
were eluted a t  100 and 180 mM NaCI, respectively. Peptide fractions 
were dialyzed against 1 m~ potassium phosphate, pH 7.0, a t  4 "C, 
loaded onto 2-ml hydroxyapatite column equilibrated with 1 mM potas- 
sium phosphate, pH  7.0, and eluted with a 1-300 mM potassium phos- 
phate gradient. SDCL and CDCL were eluted a t  80 and 60 mM potas- 
sium  phosphate, respectively, dialyzed against 20 mM Na-Hepes, pH 7.4, 
0.2 m~ phenylmethylsulfonyl fluoride and 10 PM leupeptin, concen- 
trated with a Centricon 10 concentrator (Amicon,  Beverly, MA), frozen 
in liquid nitrogen, and stored a t  -80 "C. 
Isolation of SR Vesicles-Heavy SR vesicles were prepared from rab- 
bit skeletal muscle and  canine heart muscle in the presence of protease 
inhibitors as  previously described (15, 16). 
Purification and Reconstitution of 30 S RYR"The CHAPS-solubi- 
lized 30 S RYR complex was isolated by rate density gradient centrifu- 
gation in the presence of phospholipid and protease inhibitors (17). The 
purified RYR was reconstituted  into liposomes by removal of CHAPS by 
dialysis for 40 h a t  4 "C against 10 mM Na-Hepes, pH 7.4, buffer con- 
taining 0.5 M NaCI, 100 p~ EGTA, 200 PM Ca2+, 0.2 mM phenylmethyl- 
sulfonyl fluoride, and 0.5 mM dithiothreitol. The reconstituted RYR was 
sedimentated by centrifugation (200,000 x g  for 2 h), resuspended in 20 
mM Na-Hepes, pH 7.0,0.25 M NaCI, 100 PM EGTA, 200 PM CaCI,, rapidly 
frozen, and stored a t  -80 "C. Before use, samples were thawed, once 
more frozen and thawed, and sonicated for 3 x 20 s in a water bath 
sonicator to generate proteoliposomes with an average diameter of 
1,500 A.z 
Single Channel Recordings-Single channel measurements were 
performed following the incorporation of the purified, CHAPS-solubi- 
lized skeletal muscle 30 S RYR/Ca2* release  channel complex into Muel- 
ler-Rudin type planar lipid bilayers containing phosphatidylethanol- 
amine, phosphatidylserine, and phosphatidylcholine in the ratio of 
5:3:2, respectively (50 mg/ml phospholipid in n-decane). A symmetrical 
solution of 20 mM K-Pipes, pH 7.0,0.25 M KCI, 50 PM free Ca2+ was used 
to incorporate single channels. Before addition of DCLs, channel open 
probability (Po) was lowered to <0.1 by decreasing the free Ca2+ con- 
centration in  the cis chamber by addition of EGTA. Recordings were 
made with an Axopatch-1D amplifier and filter setting at  5 kHz and 
stored on VCR tape. Unless otherwise specified, replayed data were 
digitized a t  the sampling rate of 5 kHz and filtered a t  1.5 kHz. Channel 
open probabilities and lifetimes of open and closed events were deter- 
mined by 50% threshold  analysis as previously described (18). 
PHlRyanodine Binding-Unless otherwise indicated, SR vesicles or 
proteoliposomes containing the purified RYR were incubated a t  12 "C 
for 20 h in 100 pl of reaction mixture  containing 20 mM Na-Hepes, pH 
7.4, 0.1 M NaCl, 100 p~ EGTA, 125 p~ CaCI,, 5 m~ AMP, 0.5 mM 
phenylmethylsulfonyl fluoride, 100 p~ leupeptin, and 5 nM [3Hlryano- 
dine. Bound and  free f3H1ryanodine were determined as  described else- 
where (19). Nonspecific binding was determined in  the presence of a 
1,000-fold excess of unlabeled ryanodine. 
RESULTS 
Expression and  Purification of DCLs-The cytoplasmic loops 
between transmembrane  repeats I1 and I11 of the DHPR a1 
subunit (DCL) from rabbit  skeletal muscle (SDCL) and  rabbit 
cardiac muscle (CDCL) (Fig. lA) were expressed in E. coli, 
along with an  amino-terminal (12 amino acid residues) Tag 
sequence. Both peptides were present  in  the soluble fraction of 
the cellular extracts  and purified as described under "Experi- 
mental Procedures." SDS-polyacrylamide gel electrophoresis 
indicated a purity of greater than 90% for SDCL, while CDCL 
was  about 98% pure (Fig. 1B). The two peptides  were  identified 
H.-B. Lee and G. Meissner, unpublished studies. 
Ca2+ Release Channel 
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SDCL EAESLTSAQKAKAEERKRRKSRGL.PDKTEEEKSVMAKK.LEQ. ..... 707 
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FIG. 1. Analysis of purified SDCL and CDCL by SDSPAGE and 
immunoblot. A, comparison of deduced amino acid sequences of  SDCL 
(Glum to Leu791) (8) and CDCL  (Asp788 to GlngZ2) (9). Numbering of 
amino acid residues in a1 subunit of DHPRs is given on the right. B and 
C, purified proteins (5 pg) were run on a 12% polyacrylamide gel.  Pro- 
teins were stained with Commassie Brilliant Blue R-250 ( B ) ,  and fol- 
lowing their  transfer onto polyvinylidene difluoride membranes probed 
with T7.Tag  monoclonal antibody (C) .  Molecular mass values (in kilo- 
daltons) of standard proteins (M) are indicated on the left. 
on Western  blots using a monoclonal antibody  directed against 
the NH2-terminal Tag sequence present  in  the two DCLs (Fig. 
1C). 
Single  Channel Recordings-The effects of a possible func- 
tional interaction of the purified SDCL and CDCL with the 
skeletal muscle RYR were first  tested  in single channel meas- 
urements. Single channels were recorded in symmetric 250 mM 
KC1 medium,  with K+ as  the  current carrier.  Since we found in 
preliminary experiments  that  the two peptides  activated the 
RYR, channels were recorded with a suboptimally activating 
[Ca2+] in the cis (SR cytoplasmic) chamber (Fig. 2A, upper 
panels). The two middle panels of Fig. 2A show that addition of 
48 nM SDCL to the cis chamber resulted in  an  increase  in Ca2+ 
release  channel activity without an  apparent change in single 
channel conductance. Three  minutes  after addition of the pep- 
tide, channel Po increased from 0.04 to 0.71. A similar large 
activation was observed in four (out of four)  experiments (Table 
I). Removal of SDCL by perfusion of the cis chamber decreased 
channel open probability to Po = 0.003 (Fig. 2A, bottom panels), 
showing that  the activation of the channel by  SDCL was  re- 
versible. In  other single channel recordings (not shown), addi- 
tion of micromolar concentrations of ryanodine modified the 
K+-conductance of the SDCL-activated channels  in a manner 
highly characteristic for the  skeletal Ca2+ release channel (191, 
thus confirming that ryanodine-sensitive channels were re- 
corded in  this study. 
Fig. 2B depicts  cumulative open and closed time histograms 
constructed from 7 s single channel recordings similar  to those 
shown in Fig. 2A, two left top panels.  In  the absence of SDCL, 
the  best  fits were  obtained using one and two exponential mod- 
els for the open and closed time histograms, respectively. These 
results indicated the presence of at least one open and two 
closed channel states. The presence of additional short-lived 
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FIG. 2. Effect of SDCL on single  channel  activity  of  the  purified 
skeletal Cas* release  channel. A, single channel currents, shown as 
upward deflections, were recorded in symmetrical 0.25 M KC1 media 
with 6.1 PM free Ca2+ cis and 50 VM free Ca2+ trans. Left  panels, top 
trace,  Control, Po = 0.038; middle  trace, 3 min after addition of 48 nM 
SDCL cis, Po = 0.707; bottom  trace, after perfusion of cis chamber  with 
0.25 M KC1 buffer containing 6.1 PM free Ca2+, Po = 0.003. Holding 
potential = 30 mV. Right  panels show values of Po as fractional open 
times during successive sweeps of 250 ms. Zero times of the middle and 
bottom panels correspond  to  times of addition of SDCL and completion 
of perfusion, respectively. Sampling rate was 500 Hz and filter fre- 
quency was 100 Hz. B,  cumulative open (left  panels) and closed (right 
panels) time  histograms of recordings in absence (A, upper left panel) 
and presence of 48 nM SDCL cis (A, middle left panel 1. 
open and closed channel states was highly likely, however, 
since our bilayer  frequency  resolution  limited  detection of open 
and closed events  to those with  durations of 0.2 ms  and longer. 
Addition of SDCL cis resulted in the  appearance of a second 
resolvable open channel  state  and decreased the  durations of 
the closed events (Table I). 
It  has been shown that  the loop region between transmem- 
brane  spanning  repeats I1 and I11 of DHPR a1 subunit is a 
major determinant of the  type of E-C coupling that  exists  in 
muscle cells (13). Dysgenic mouse cells expressing a1 DHPR 
chimeras containing the  skeletal muscle 11-111 loop exhibited 
skeletal-type E-C coupling, whereas cells expressing chimeras 
with the  cardiac 11-111 loop showed cardiac-type E-C coupling. 
We found that cis CDCL was as effective as SDCL in  activating 
the  skeletal muscle  Ca2+ release  channel (Fig. 3 A ,  upper and 
middle panels). A similar activation by CDCL was observed in 
five (out of five) experiments. The activation of the release 
channels by  CDCL was reversible  (Fig. 3A, bottom panel),  as 
was observed for SDCL (Fig. 2). 
In  other  experiments, 100 nM SDCL cis ( n  = 2) and 150 nM 
CDCL cis (n = 3) were without an effect on single channel 
activity of the  canine cardiac  Ca2+  release channel  (not shown). 
Thus, single channel measurements suggested that the two 
DCLs directly interacted with the purified, reconstituted  skel- 
etal muscle Ca2+ release channel,  but not the cardiac release 
channel. 
The effects of  BSA (Fig. 3B)  and several other polypeptides 
(see “[3H]Ryanodine Binding” below) were tested to assess  the 
specificity of activation of the  skeletal Ca2+  release channel by 
the two DCLs. BSA cis was less effective than  the DCLs in 
activating single skeletal muscle release channels (Fig. 3B). 
Subsequent addition of SDCL further activated the  channel, 
although to a lesser  extent  than  in  the absence of BSA. At 
concentrations ranging from 260-1700 nM, BSA activated the 
skeletal  channel by a  factor of 5.0 f 3.8 (n  = 51, as compared to 
40 f 10-fold activation by -50 nM SDCL. 
PHlRyanodine Binding-The neutral  plant alkaloid  ryano- 
dine has been shown to bind with nanomolar affinity to  the 
mammalian  Ca2+ release channels  in a manner  that correlates 
well with the functional state of the  channels (20-22). There- 
fore, we also used r3H]ryanodine binding to investigate the 
mechanism of activation of the  Ca2+ release channel by SDCL 
and CDCL. The effects of the two DCLs on r3H1ryanodine bind- 
ing to the  release  channel were tested  using conditions (see 
“Experimental Procedures”) that  resulted  in - 10% occupation 
of the channel’s high-affinity [3Hlryanodine  binding sites  in  the 
absence of added  peptide. Addition of SDCL to heavy skeletal 
muscle SR vesicles increased  [3Hlryanodine  binding  in  a dose- 
dependent  manner,  resulting  in  about 1.5-fold stimulation at  1 
p~ and a nearly 2-fold increase at  10 PM SDCL (Fig. 4). BSA 
was similarly effective, whereas CDCL was more effective than 
SDCL, increasing r3H1ryanodine binding threefold a t  10 PM. 
Low concentrations (1 PM) of polylysine ( M ,  26,300)  increased 
[3H]ryanodine binding nearly 4-fold, whereas  higher concen- 
trations (10 p) were less effective. A similar dose-dependent 
activation and inhibition of the  skeletal muscle Ca2+ release 
channel by polylysine was observed in Ca2+ release measure- 
ments with heavy rabbit  skeletal muscle SR vesicles (23). 
Fig. 5 shows that SDCL and CDCL potentiated r3H]ryano- 
dine binding to the purified, reconstituted RYR. This result 
suggested that, in agreement  with  the single channel  measure- 
ments,  the effect of the two DCLs  on the RYR is  due  to a direct 
interaction  not mediated by other proteins. The specificity of 
the interaction of the two DCLs with the  skeletal RYR was 
assessed by testing  the effects of other randomly chosen poly- 
peptides in  potentiating r3H]ryanodine binding and by using 
cardiac SR vesicles (Fig. 5). For comparative  purposes,  poten- 
tiation of [3Hlryanodine  binding to  skeletal SR vesicles by  BSA 
and polylysine (1 PM) already shown in Fig. 4, is included in Fig. 
5. In  contrast  to  these proteins, insulin, cytochrome c and poly- 
glutamate ( M ,  13,300) were without an effect. Fig. 5 further 
shows that  the two DCLs did not significantly increase [3H] 
ryanodine  binding to cardiac SR vesicles. On the  other  hand, 
BSA and polylysine increased  [3Hlryanodine  binding to cardiac 
SR vesicles. The extent of potentiation  was less  than  that ob- 
served for skeletal SR vesicles, however. 
SDCL and CDCL contained 12 additional amino acids in 
their  NHz-terminal  ends. These  additional residues were de- 
rived from the  parent plasmid pETlld which encoded a 33- 
amino acid peptide. Although this peptide was expressed at 
high levels, as detected by immunodotblot analysis  (not 
shown), it did not activate  the RYR since extracts of the  total 
soluble proteins from cultures of E. coli strain BL21(DE3) con- 
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TABLE I
Effect of SDCL on skeletal Cu2+ release channel open probability  and  lifetimes 
Channel open  probability (Po)  was calculated in files of 70 s, and events in files of 7 s. T~ and T= represent the channel open and closed time 
constants, respectively. Data  are shown as the mean * S.D. of four experiments. 
ms n 
Control 0.021 f 0.004 0.5 t 0.3 6.7 ? 3.0  53.6 ? 23.8 259 f 139 
SDCL  0.717 & 0.060 1.1 t 0.3 5.7 f 4.0 0.7 f 0.1 6.8 f 6.9  2073 f 809 
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FIG. 3. Effects of CDCL and B8A on single  channel  activity of 
the  purified  skeletal Cas+ release channel. A, single channel cur- 
rents, shown as downward  deflections,  were  recorded in symmetrical 
0.25 M KC1 media containing 50 p~ free CaZ+. Holding potential = -30 
mV. Top truce,  control, Po = 0.057; middle  truce, after addition of 100 n~ 
0.25 M KC1 buffer containing 50 p~ free Ca2+, Po = 0.099. B ,  single 
CDCL cis, Po = 0.920; bottom truce, after perfusion of cis chamber with 
channel currents, shown as upward deflections,  were  recorded in sym- 
metrical 0.25 M KC1 media containing 9.7 p~ free Ca2+ cis and 50 p~ free 
Ca2+ trans  (top  truce, Po = 0.0051,  following the successive addition of 
260 n~ BSAcis  (middle  truce, Po = 0.019) and 64 rn SDCL cis (bottom 
trace, Po = 0.099).  Holding potential = 30 mV. 
taining plasmid pETlld were without an effect  on  [3H]ryano- 
dine binding. 
Scatchard analysis of [3Hlryanodine binding data (Fig. 6) 
showed that SDCL and CDCL increased the binding affinity 
(KO) without significantly affecting the B,,, value of  L3H1 
ryanodine binding to skeletal SR  vesicles  (Table 11). L3H1 
Ryanodine binding was affected in  a comparable manner by 
ClO;, an activator of  E-C coupling in skeletal muscle (24). In 
contrast, BSA significantly increased the B,, but not KD value 
of [3H]ryanodine binding (Fig. 6, Table 11). The interaction of 
SDCL with the skeletal muscle Ca2+ release channel was also 
characterized by determining its activating effects in the pres- 
ence of  CDCL,  BSA, and polylysine. The activating effects of 10 
p~ SDCL and 1 p~ polylysine (Fig. 5) were additive, whereas no 
or only small further increases were measured in assay media 
containing 10 p~ CDCL or 10 p~ BSA (not shown). Taken 
together, the [3H]ryanodine binding studies suggested that 
SDCL and CDCL likely activate the skeletal muscle Ca2+ re- 
lease channel by a similar mechanism, but  that  there exist 
significant differences with regard to their action on the skel- 
etal  and cardiac muscle RYR isoforms. 
DISCUSSION 
Expression studies with dysgenic  muscle cultures have 
shown that  the putative cytoplasmic 11-111  loop  of the skeletal 
and cardiac muscle DHPR a1 subunits plays a critical role in 
determining the mode of E-C  coupling. In  this study, the two 
DCLs were expressed and purified, and  their functional inter- 
action with the ryanodine receptor was examined in vitro using 
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FIG. 4. Effect of peptides on [SH]ryanodine  binding to skeletal 
SR vesicles. SR vesicles (120 pg proteidml) were incubated with 5 I“ 
PHIryanodine and indicated amounts of SDCL (open circle), CDCL 
(closed circle),  BSA  (open  triangle),  or polylysine (closed triangle) as 
described under “Experimental Procedures.” Data (means f S.D.) are 
the averages of three experiments camed out in duplicate. B,, value 
for c3H1ryanodine binding to skeletal SR vesicles in the absence of 
peptides was 9.8 pmol/mg. 
isolated membrane and receptor preparations. These studies 
led to  two  new observations that may have important implica- 
tions for the E-C  coupling mechanism in muscle. First,  the  data 
reported here provide the first evidence  for a direct functional 
interaction of the cytoplasmic 11-111 loop  of the DHPR a1 sub- 
unit with the SR Ca2+ release channel. Second, both SDCL and 
CDCL activated the skeletal, but not cardiac, release channel, 
indicating that  in addition to the DHPR, the SR Ca2+ release 
channel may  play an important role in determining the cou- 
pling mode in  striated muscle. 
Several other proteins have been suggested to associate with 
the DHPR and/or RYR, and thereby to possibly link or stabilize 
the interaction between the two receptor complexes. These in- 
clude triadin,  a SR membrane protein (25, 26), and glycolytic 
enzymes such as aldolase (27) and glyceraldehyde-3-phosphate 
dehydrogenase (28). The present study shows that SDCL acti- 
vates  the purified SR  Ca2+ release channel, thus suggesting a 
direct interaction between the skeletal DHPR and RYR.  To our 
knowledge, no direct functional or structural linkage between 
the DHPR and RYR has yet been demonstrated. One reason 
may be that  the conditions that  are required to maintain  the 
two purified receptors in solution disfavor such an interaction. 
Expression of  cDNAs encoding chimaeras with the skeletal 
11-111 cytoplasmic loop in dysgenic  myocytes resulted in skel- 
etal-type E-C  coupling, whereas expression of cDNAs with the 
cardiac 11-111 loop elicited cardiac-type coupling (13). This sug- 
gested that of the two  DCLs,  SDCL should have been the more 
likely candidate of altering skeletal muscle Ca2+ release chan- 
nel activity. An unexpected finding was therefore that both 
DCLs were able to activate the skeletal RYR. Indeed, of the two 
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FIG. 5. Comparison of effects of peptides on [SHlryanodine 
vesicles. Purified, reconstituted skeletal RYR (8 pg/ml), skeletal SR 
with [3H]ryanodine (1 nM for purified RYR, 5 nM for vesicles) in  the 
vesicles (120 pg/ml), or cardiac  SR vesicles (150 pg/ml)  were  incubated 
absence (Control), or presence of SDCL (10 p ~ ) ,  CDCL (10 p ~ ) ,  BSA(l0  
p ~ ) ,  polylysine (1 p ~ ) ,  insulin (160 PM), cytochrome c (80 PM), or poly- 
glutamate (1 p~). Data  (means + S.D.) are  the averages of three or more 
experiments carried out  in duplicate. * Indicates a  significant difference 
( p  < 0.05) from control as determined by Student's paired t test. 
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FIG. 6. Effects of peptides on [SHlryanodine binding to skeletal 
SR vesicles. Skeletal SR vesicles (120 pg/ml) were incubated with 
[3H]ryanodine (5-200 nM) a t  12 "C for 48  h in  the absence of peptide 
(open circle), or presence of 10 p~ SDCL (closed  circle), 10 p~ BSA(open 
triangle), or 10 p~ CDCL (closed triangle). Inset, Scatchard plot of 
[3Hlryanodine binding. 
DCLs, the cardiac peptide appeared to be more effective in 
PHIryanodine binding  experiments. The amino acid sequences 
of SDCL and CDCL show 52% identity  and 73% similarity (Fig. 
lA). Accordingly, some of the sequences shared by the two 
DCLs are likely responsible for activating the RYR. Experi- 
ments of identifying these sequences are  currently  under way 
in  our laboratory. Other portions of the DHPR a1 subunit  such 
as the cytoplasmic loop between transmembrane regions  I and 
I1 also have been reported to play a role, albeit a minor  one, in 
determining  the coupling mode in dysgenic muscle cells. I t  is 
TABLE I1 
Effects of DCLs and BSA on B,, and KD values of PHlryanodine 
binding to skeletal SR vesicles 
B,, and KD values  were  determined by Scatchard analysis  as de- 
scribed in Fig. 6. Results  are given as the  mean * S.D. with number of 
experiments  indicated. 
PHIRyanodine  binding 
Peptides 
Bmax KD n 
pmol I mg protein nM 
Control 9.2 k 0.8 12.8 * 0.8  4 
SDCL (10 p ~ )  10.3 f 1.3 7.1 * 0.8" 3 
CDCL (10 p ~ )  11.1 * 1.4 7.0 2 0.9"  3 
BSA (10 p ~ )  14.0 k 0.7" 10.1 * 0.4  4 
a Significant difference ( P  < 0.05) from control as determined by 
Student's paired t test. 
possible that lack of these  other  interactions may result in  a 
decreased specificity of  DCL-RYR interaction.  A partial loss of 
specificity would  be also  consistent  with  our  observation that 
BSA activated the skeletal muscle RYR. Its action could be 
distinguished from that of the DCLs, however, by analyzing the 
mechanism of potentiation of  L3H1ryanodine binding by 
Scatchard  analysis (Fig. 6). Whereas BSA increased the bind- 
ing capacity (Elma) without  significantly  affecting the  binding 
constant &), the two DCLs increased the KO value  without 
affecting the B,, value,  implying that  the open-channel con- 
figuration induced by the DCLs (Figs. 2 and 3) exhibits an 
increased ryanodine binding affinity. Also, in contrast to the 
DCLs, BSA and polylysine were able to activate the cardiac 
RYR as well (Fig. 5). Furthermore, ineffectiveness of cyto- 
chrome c,  insulin,  and polyglutamate in  altering  skeletal RYR 
activity  ruled out a  ubiquitous  activation of the  skeletal muscle 
RYR  by proteins  and polypeptides. 
Significantly higher concentrations of the DCLs were re- 
quired  to  activate  the RYR in [3Hlryanodine binding experi- 
ments  than  in single channel  measurements. Although the  rea- 
sons for these differences are not well understood, they are 
consistent with other observations in our laboratory which 
have shown a higher sensitivity of the  channel following its 
reconstitution into  planar lipid  bilayers of the Mueller-Rudin 
type. In bilayer measurements, activation of single channel 
activity by SDCL and CDCL was fully reversible. This excludes 
the possibility of a chemical modification reaction by a  contami- 
nating protease or some other protein modifying enzyme. 
The RYR ion channel  has been purified as a 30 S protein 
complex comprised of four polypeptides of -5000 amino acid 
residues each. There is morphological evidence to suggest that, 
at  least  in some skeletal muscle in a  subpopulation of RYRs, 
each of the four subunits may be linked to one DHPR (29). The 
high extent of channel activation in  the single channel mea- 
surements suggests that the DCLs may interact with these 
sites,  although  this  remains  to be demonstrated.  Further  stud- 
ies are required to  answer several additional questions: Why do 
the DCLs activate  the RYR? Does the action of the DCLs cor- 
respond to  that of the DHPRs during  an action  potential, or 
how does the binding of the DCLs to  the RYR alters  the regu- 
lation by other endogenous effectors? The very large  subunits of 
the RYR presumably allow a complex pattern of regulation 
since functional studies  have shown that  the  channel may be 
regulated, in addition to the DHPR, by various endogenous 
effectors including Ca2+, Mg2+, ATP, and calmodulin (30). 
The role of the RYR in  determining  the coupling mode in 
skeletal  and cardiac muscle was  not investigated by Tanabe et 
al. (11-131, because all their  studies were done with cells ex- 
pressing  the  skeletal RYR isoform. We found that  the  skeletal 
but not  cardiac RYR isofonn was activated by the DCLs. This 
result supports the mechanical coupling model in skeletal 
muscle, and also  implies an  important role for both the DHPR 
6516 DCL Activates  SkeletalCa2+ Release  Chann l 
and Ca2+  release channel  in  determining  the coupling mode in 
striated muscle. 
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